Non-Laboratory-based Cannabis Testing Market Size & Share 2023 to 2032
Market Size by Technology (Chromatography, Spectroscopy {Near-infrared (NIR) Spectroscopy}), Test Type (Potency, Water Testing, Moisture Testing) & Global Forecast.
Report ID: GMI6901
|
Published Date: October 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Non-Laboratory-based Cannabis Testing Market Size
Non-Laboratory-Based Cannabis Testing Market accounted for USD 46.5 million in 2022 and is anticipated to reach USD 186.8 million by 2032 with a CAGR of 14.5%. This substantial growth is attributed to several key factors, including the increasing legalization of cannabis for medical purposes and the expanding research efforts exploring various medical applications of cannabis.
Non-Laboratory-based Cannabis Testing Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Portable non-laboratory-based cannabis testing devices offer distinct advantages by significantly improving the accessibility of cannabis testing capabilities. These compact and portable devices empower a wide range of users, including consumers, growers, and dispensaries, as they enable testing to take place outside of traditional laboratory settings. Their portability allows for on-site testing at various locations, including cultivation facilities, dispensaries, and even outdoor cultivation sites.
Non-laboratory-based cannabis testing refers to portable/handheld devices designed for on-the-go assessment of various aspects of cannabis testing [Tetrahydrocannabinol (THC), Cannabidiol (CBD), etc.] without the need for a traditional laboratory setup. These portable devices are often used to quickly evaluate different characteristics of cannabis, including potency, quality, safety, and authenticity.
COVID-19 Impact
The COVID-19 pandemic had moderate impact on the non-laboratory-based cannabis testing industry. Supply chain disruptions, a common challenge across industries during the pandemic, have affected the production and distribution of components and devices, occasionally leading to shortages in the cannabis testing device sector. Fieldwork and on-site testing in various regions have encountered obstacles due to travel restrictions and safety concerns. Researchers and professionals using portable testing devices have had to adapt their practices and adhere to local health guidelines, which has sometimes slowed down research and testing efforts. Finally, economic uncertainties resulting from the pandemic have impacted businesses in the cannabis industry, including those involved in the development and distribution of portable testing devices.
Non-Laboratory-based Cannabis Testing Market Trends
Several regions have taken steps to legalize or decriminalize medical cannabis to provide patients with access to potentially beneficial treatments. Therefore, the growing legalization of cannabis for medical purposes worldwide has spurred the development and adoption of non-laboratory-based cannabis testing solutions. These portable testing devices play a vital role in ensuring the quality, safety, and compliance of medical cannabis products. As these regions have embraced medical cannabis programs, there has been an increasing need for rapid and accessible testing methods to verify the potency and safety of cannabis products. Portable devices such as CannaDx analyzer allow healthcare professionals, dispensaries, and patients to assess the cannabinoid content, particularly the levels of THC and CBD, in medical cannabis products quickly and conveniently.
Non-Laboratory-based Cannabis Testing Market Restraining Factors
The lack of uniformity in quality standards is a significant challenge in the cannabis industry, globally. The absence of consistent and standardized quality control measures has led to variations in the quality and safety of cannabis products. An example that highlights this issue is the disparity in quality standards across European countries. The regulation of cannabis and its derivatives varies from one region to another. Each region has its own set of rules and quality standards for medical cannabis, which can create inconsistencies in product quality.
For instance, the potency limits for THC and CBD, allowable contaminants, and labelling requirements can differ significantly between European nations. This lack of uniformity can make it challenging for patients, healthcare professionals, and industry stakeholders to navigate the complex regulatory landscape.
Non-Laboratory-based Cannabis Testing Market Analysis
Based on technology, the market is segmented into chromatography, spectroscopy, and other technologies. The spectroscopy segment is further sub-segmented into near-infrared (NIR) spectroscopy and other spectroscopy. As of 2022, the spectroscopy segment held the largest market share, accounting for 30 million of the total market revenue. This segment is expected to continue growing at a rate of 14.9% from 2023 to 2032. Spectroscopy provides the unique capability of simultaneously measuring various parameters in cannabis samples, including the levels of cannabinoids such as THC and CBD, moisture content, and the presence of contaminants. This comprehensive analytical capacity is particularly appealing to users who seek a holistic understanding of their cannabis products. Additionally, spectroscopy-based devices offer rapid measurements, often delivering results within minutes.
Based on test type, the non-laboratory-based cannabis testing market is classified into potency testing, water testing, moisture testing, and other test types. The potency testing held significant market share of 64.6% in 2022. Portable non-laboratory-based cannabis testing devices designed for potency testing are playing a pivotal role in revolutionizing the way cannabis products are assessed for their cannabinoid content. These devices offer several distinct advantages, making them valuable tools in the cannabis industry. The portable devices enhance accessibility to cannabis potency analysis. Portable potency testing devices are designed to be user-friendly, requiring minimal training. This ensures that individuals with varying levels of technical expertise can utilize the technology effectively, further accessing to potency testing capabilities.
Europe non-laboratory-based cannabis testing market is projected to reach USD 82.6 million by 2032. On-site quality control assessments are crucial for ensuring that cannabis products meet regulatory standards and comply with Germany's strict legal requirements. Portable devices empower cultivators and dispensaries to conduct immediate quality checks, contributing to product consistency and safety. Also, Germany follows a pharmaceutical model for medical cannabis distribution, with products dispensed through pharmacies. This pharmaceutical approach demands rigorous quality control, including testing, to maintain product consistency and safety.
Non-Laboratory-Based Cannabis Testing Market Share
Market players operating in the non-laboratory-based cannabis testing industry is as mentioned below:
Companies in this market are at the forefront of assessing the safety and quality of cannabis products in a constantly evolving sector. Orange Photonics, Inc., My Dx, Inc., and GemmeCert accounts for largest market share in global market. Orange Photonics, Inc. has emerged as a prominent player in the cannabis testing technology sector. It was founded with a vision to address the increasing demand for accessible and precise cannabis testing solutions. The company is well-known for its advanced technology, particularly the LightLab Analyzer, designed to offer quick, precise, and non-destructive testing of cannabis potency and composition.
Non-Laboratory-based Cannabis Testing Industry News:
The non-laboratory-based cannabis testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Technology
By Test Type
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →